BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

VERAX BIOMEDICAL INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

VERAX BIOMEDICAL INC.

via AKIN GUMP STRAUSS HAUER & FELD

4th Quarter (Oct 1 - Dec 31) · 2019Posted Jan 21, 2020Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: VERAX BIOMEDICAL INC.
Description: Medical Products Development
Location: Massachusetts · United States of America

Registrant

Firm: AKIN GUMP STRAUSS HAUER & FELD
Description: Law firm
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to blood safety; S. 2976 FY 2019 Agriculture Appropriations bill, omnibus appropriations bill.
LobbyistsSEAN D'ARCY · DANIEL GRAVER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.